Evidence map›Paper›PMID 25586183›Full record

ArticleThe Journal of biological chemistry2015

15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids.

Stacy Gelhaus Wendell, Franca Golin-Bisello, Sally Wenzel, Robert W Sobol, Fernando Holguin, Bruce A Freeman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. 12/15-lipoxygenase orchestrates murine wound healing via PPARγ-activating oxylipins acting holistically to dampen inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Lipoxin AbioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Protection ofNutrients · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Stacy Gelhaus WendellFrom the Department of Pharmacology and Chemical Biology and gstacy@pitt.edu.
Franca Golin-BiselloFrom the Department of Pharmacology and Chemical Biology and.
Sally WenzelAsthma Institute and Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and.
Robert W SobolFrom the Department of Pharmacology and Chemical Biology and University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, Pennsylvania 15213.
Fernando HolguinAsthma Institute and Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 and.
Bruce A FreemanFrom the Department of Pharmacology and Chemical Biology and freerad@pitt.edu.
University of Pittsburgh · USUPMC Hillman Cancer Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Vascular Subphenotypes of Lung DiseaseP01HL103455 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLADWIN, MARK T · 2011 to 2020
$26.1M
Redox-Derived Pulmonary Anti-Inflammatory MediatorsR01HL064937 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FREEMAN, BRUCE ALAN · 2000 to 2015
$5.6M
Redox Transduction of Nitric Oxide SignalingR37HL058115 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FREEMAN, BRUCE ALAN · 2008 to 2017
$5.2M
Novel approaches to enhance tumor cell cytotoxicity of alkylating agentsR01CA148629 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2010 to 2021
$3.4M
NITRIC OXIDE REGULATION OF VASCULAR OXIDANT INJURYR01HL058115 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FREEMAN, BRUCE ALAN · 1998 to 2007
$3.3M
DNA repair deficient cells for analysisR44GM087798 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2010 to 2011
$2.5M
DNA Repair-on-a-Chip: Spatially Encoded Microwell ArraysR44ES021116 · NIEHS · TREVIGEN, INC. · PI ENGELWARD, BEVIN P., GEORGE, JAY · 2013 to 2015
$1.5M
CometChip: Enabling Translation of DNA Damage and Repair AssaysR21ES019498 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ENGELWARD, BEVIN P., SOBOL, ROBERT W · 2011 to 2012
$434k
DNA Repair-on-a-Chip: Spatially Encoded Microwell ArraysR43ES021116 · NIEHS · TREVIGEN, INC. · PI ENGELWARD, BEVIN P., GEORGE, JAY · 2011 to 2011
$319k
Discovery Tools for Chemotherapy Resistance to Cell Death.R43GM099213 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2012 to 2012
$217k
DNA repair deficient human cells for genomic variation analysisR43GM087798 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2009 to 2009
$200k
NCI NIH HHS CA047904NCI NIH HHS CA148629NCI NIH HHS P30 CA047904NCI NIH HHS R01 CA148629NHLBI NIH HHS P01 HL103455NHLBI NIH HHS P01-HL103455NHLBI NIH HHS R01 HL058115NHLBI NIH HHS R01-HL058115NHLBI NIH HHS R01 HL064937NHLBI NIH HHS R01-HL64937NHLBI NIH HHS R37 HL058115NIEHS NIH HHS ES019498NIEHS NIH HHS ES021116NIEHS NIH HHS R21 ES019498NIEHS NIH HHS R43 ES021116NIEHS NIH HHS R44 ES021116NIGMS NIH HHS GM087798NIGMS NIH HHS GM099213NIGMS NIH HHS R43 GM087798NIGMS NIH HHS R43 GM099213NIGMS NIH HHS R44 GM087798
6 · The paper itself

Abstract

15-Hydroxyprostaglandin dehydrogenase (15PGDH) is the primary enzyme catalyzing the conversion of hydroxylated arachidonic acid species to their corresponding oxidized metabolites. The oxidation of hydroxylated fatty acids, such as the conversion of prostaglandin (PG) E2 to 15-ketoPGE2, by 15PGDH is viewed to inactivate signaling responses. In contrast, the typically electrophilic products can also induce anti-inflammatory and anti-proliferative responses. This study determined that hydroxylated docosahexaenoic acid metabolites (HDoHEs) are substrates for 15PGDH. Examination of 15PGDH substrate specificity was conducted in cell culture (A549 and primary human airway epithelia and alveolar macrophages) using chemical inhibition and shRNA knockdown of 15PGDH. Substrate specificity is broad and relies on the carbon position of the acyl chain hydroxyl group. 14-HDoHE was determined to be the optimal DHA substrate for 15PGDH, resulting in the formation of its electrophilic metabolite, 14-oxoDHA. Consistent with this, 14-HDoHE was detected in bronchoalveolar lavage cells of mild to moderate asthmatics, and the exogenous addition of 14-oxoDHA to primary alveolar macrophages inhibited LPS-induced proinflammatory cytokine mRNA expression. These data reveal that 15PGDH-derived DHA metabolites are biologically active and can contribute to the salutary signaling actions of Ω-3 fatty acids.

Indexed as

Signal TransductionBronchoalveolar Lavage FluidCell Line, TumorCells, CulturedCytokinesDocosahexaenoic AcidsEpithelial CellsFatty Acids, Omega-3Fatty Acids, UnsaturatedGene ExpressionHumansHydroxylationHydroxyprostaglandin DehydrogenasesLipidsLipopolysaccharidesMacrophages, Alveolar15-hydroxyprostaglandin dehydrogenaseCytokinesDocosahexaenoic AcidsFatty Acids, Omega-3Fatty Acids, UnsaturatedHydroxyprostaglandin DehydrogenasesLipidsLipopolysaccharidesEicosanoidFatty Acid OxidationLipid OxidationLipid SignalingSignaling

Identifiers

PMID25586183
PMCPMC4342494
OpenAlexW1989467711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.